SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SRF commences pharma intermediates plant at Dahej

13 Apr 2023 Evaluate

SRF has commissioned pharma intermediates plant at Dahej on April 12, 2023. The said project has been capitalized at an aggregate cost of Rs 223 crore.  In January 2022, the company had received approval from its board of directors for a project to create pharma intermediates plant for undertaking precursor processes for production of pharma products at Dahej.

SRF is a leader in refrigerants, engineering plastics and industrial yarns in India. The company also manufactures polyester films and fluoro specialties. Besides India, SRF has a presence in Dubai, South Africa and Thailand.

SRF Share Price

2520.85 -30.55 (-1.20%)
05-May-2026 12:34 View Price Chart
Peers
Company Name CMP
BASF India 3638.30
Tata Chemicals 792.10
SRF 2520.85
Pidilite Inds. 1356.65
Deepak Nitrite 1766.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×